Piramal Pharma Secures SBTi Validation for 42% GHG Reduction by 2030
Piramal Pharma has received official validation from the Science Based Targets Initiative (SBTi) for its near-term greenhouse gas (GHG) emission reduction targets. The company’s commitment…